Revenue of Fosun Pharmaceutical 2019-2022
BioNTech in the early days of the COVID-19 pandemic in 2020.
In 2022, the Chinese pharmaceutical firm Fosun Pharmaceutical generated almost 44 billion yuan of revenue, representing a growth of 12.7 percent from the previous year. The company is one of the leaders in the Chinese pharmaceutical sector, which formed a strategic alliance with